IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Necrotizing Enterocolits

Review Article, Volume 05 Issue 1 – January to March 2012

Authors

Dr. Jayasree C, Clinical Professor, Department of Paediatrics, Amrita Institute of Medical Sciences, Kochi, Kerala.


Abstract

Necrotizing Enterocolits is the most common acquired gastrointestinal disease that occurs in the neonates especially the premature infants. As the advances in neonatal intensive care have progressed and as premature newborns are surviving long enough for the disease to develop, the incidence of NEC has increased. There is an inverse relationship between NEC and the gestational age, the extreme preterm babies being at highest risk. Although it is mainly a disease of preterms, it can occur in terms and late preterms. Coagulation necrosis is the hallmark of the pathologic findings of NEC. Fetal intestine is a relatively dormant organ and the low level of blood flow and oxygen delivery is adequate to meet its limited tissue oxygen demand. Postnatally, the gut is a site of intense metabolic activity with a dramatic increase in growth during the first weeks of life. The basal vascular resistance within the newborn intestinal circulation significantly decreases in the first several days after birth.
Keywords: Necrotizing Enterocolits, Neonate, Preterm baby


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician